StockNYSEDGX

Quest Diagnostics

$236.59

+3.59 (+1.54%)today

Valuation & earnings

P/E ratio: 25.14
Forward P/E: 19.62
EPS (ttm): $9.41
Forward EPS: $12.06
Price/book: 3.46
PEG ratio: 1.52
Dividend yield: 1.45%
Payout ratio: 26.11%

Financials (ttm)

Revenue (ttm): 11.6B
Revenue growth: 10.2%
Profit margin: 9.19%
Return on equity: 14.6%
Total cash: 626M
Total debt: 6.4B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	2.5	2.6	+3.85%
Dec 31, 2025	2.36	2.42	+2.63%
Mar 31, 2026	2.37	2.5	+5.61%
Jun 30, 2026	2.82	3.12	+10.51%

Next earnings date: Oct 22, 2026

Analyst view

Consensus ratingBuy17 analysts

Strong buy 2Buy 7Hold 7Strong sell 1

12-month price targetsImplied upside: +4.71%

204

247.73

265

LowCurrent priceHigh

Dividends

Dividend yield: 1.45%
Dividend (annual): $3.44
Ex-dividend date: Oct 6, 2026

Recent payments

Jul 8, 2026 · $0.86Apr 6, 2026 · $0.86Jan 13, 2026 · $0.80Oct 3, 2025 · $0.80Jul 7, 2025 · $0.80

Key stats

Previous close: $233.00
Day range: 233.55 – 237.29
52-week range: 171.18 – 248.84
Volume: 926.9K
Avg. volume: 1M
Market cap: 26.1B
Beta: 0.55
52-week change: 25.19%
Currency: USD

Profile

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides services under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers commercial clinical l(English)

Sector: Healthcare
Industry: Diagnostics & Research
Employees: 46,000
Headquarters: Secaucus, United States

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.